A randomized trial comparing an intensive to a standard diagnostic approach showed the suspected etiology, in cases of MI with nonobstructive coronary arteries, is often wrong.

Advances in pharmacotherapy for stable angina have produced a wide choice of drugs with various mechanisms of action, potentially enabling individualized, patient-specific treatment strategies to be ...

In a new publication from Cardiovascular Innovations and Applications, Wen-Yuan Ding, Jia-Min Li, Fei Zheng, Li-Li Wang, Xin-Yi Wei and Guo-Hua Li from Shandong Provincial Qianfoshan Hospital, Ji'nan, ...

Objective To derive a risk score for the combination of death from all causes, myocardial infarction, and disabling stroke in patients with stable symptomatic angina who require treatment for angina ...

Atherosclerotic coronary artery disease (CAD) affects the coronary arteries, which deliver blood to the myocardium. CAD symptoms include stable angina, reviewed here, and acute coronary syndromes (ACS ...

This news was covered by the Medical Dialogues Bureau, which was present at the TCT Conference 2025 held in San Francisco, USA.A stratified treatment, based on comprehensive diagnostic ...

Vol. 181, Supplement 3. The Potential Etiologic Role of Chlamydia pneumoniae in Atherosclerosis A Multidisciplinary Meeting to Promote Collaborative Research (Jun., 2000), pp. S449-S451 (3 pages) ...

Bristol Myers and Johnson & Johnson ended the Librexia ACS trial after an interim review showed low efficacy, while AF and ...

This appraisal covers the use of myocardial perfusion scintigraphy (MPS) using single photon emission computed tomography (SPECT) in the diagnosis and management of angina and myocardial infarction.